Nutex revenue more than trebles in H1
Hungarian dietary supplement maker Nutex's first-half revenue more than tripled from the same period a year earlier, but it still ended up in the red because of financial losses, the company's H1 report published late Wednesday shows.
Revenue jumped 241% to HUF 1.28 billion during the period.
Nutex announced in March plans to expand on its existing markets this year.
Direct cost of sales were up 398% at HUF 751 million. Gross margin rose 136% to HUF 530 million.
General and administrative costs were up 133% at HUF 484 million.
Operating profit climbed to HUF 39 million from HUF 12 million.
The company booked a HUF 72 million net financial loss in H1, compared to a big HUF 273 million financial gain in the same period a year earlier.
Nutex had total assets of HUF 2.14 billion on June 30, up 1% from the end of 2010. Net assets fell 2% to HUF 1.5 billion. Long-term liabilities were up 14% at HUF 111 million.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.